MicroRNA expression profiles of esophageal cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 2, 2008, Pages 255-260

  Feber, Andrew ^a   Xi, Liqiang ^a   Luketich, James D ^b   Pennathur, Arjun ^b   Landreneau, Rodney J ^b   Wu, Maoxin ^a   Swanson, Scott J ^a   Godfrey, Tony E ^a   Litle, Virginia R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FROZEN SECTION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE PROBE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; RNA ISOLATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FROZEN SECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SAMPLING STUDIES;

EID: 38649140487     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.08.055     Document Type: Article

References (38)

1. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
2. Gamliel Z., and Krasna M.J. Multimodality treatment of esophageal cancer. Surg Clin North Am 85 (2005) 621-630
3. Luketich J.D., Alvelo-Rivera M., Buenaventura P.O., Christie N.A., McCaughan J.S., Litle V.R., et al. Minimally invasive esophagectomy-outcomes in 222 patients. Ann Surg 238 (2003) 486-494
4. Swanson S.J., Batirel H.F., Bueno R., Jaklitsch M.T., Lukanich J.M., Allred E., et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 72 (2001) 1918-1924
5. Chang J.T., and Katzka D.A. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma. Arch Intern Med 164 (2004) 1482-1488
6. Vizcaino A.P., Moreno V., Lambert R., and Parkin D.M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99 (2002) 860-868
7. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
8. Lagergren J., Bergstrom R., Lindgren A., and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
9. Csendes A., Smok G., Burdiles P., Quesada F., Huertas C., Rojas J., et al. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 13 (2000) 5-11
10. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA 287 (2002) 1972-1981
11. Altorki N.K., Oliveria S., and Schrump D.S. Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol 13 (1997) 270-280
12. Falk G.W., Rice T.W., Goldblum J.R., and Richter J.E. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 49 (1999) 170-176
13. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
14. Nigro J.J., Hagen J.A., DeMeester T.R., DeMeester S.R., Theisen J., Peters J.H., et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 230 (1999) 433-438
15. Tharavej C., Hagen J.A., Peters J.H., Portale G., Lipham J., DeMeester S.R., et al. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc 20 (2006) 439-443
16. Larghi A., Lightdale C.J., Memeo L., Bhagat G., Okpara N., and Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 62 (2005) 16-23
17. Sharma V.K., Wang K.K., Overholt B.F., Lightdale C.J., Fennerty M.B., Dean P.J., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
18. Korst R.J., and Altorki N.K. High grade dysplasia: surveillance, mucosal ablation, or resection?. World J Surg 27 (2003) 1030-1034
19. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 287 (2002) 1982-1986
20. Reid B.J., Haggitt R.C., Rubin C.E., Roth G., Surawicz C.M., Van Belle G., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19 (1988) 166-178
21. Lee R.C., Feinbaum R.L., and Ambros V. The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
22. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
23. Lu J., Getz G., Miska E.A., varez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
24. Calin G.A., Ferracin M., Cimmino A., Di L.G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353 (2005) 1793-1801
25. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (2005) 7065-7070
26. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
27. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5 (2006) 24
28. Selaru F.M., Zou T., Xu Y., Shustova V., Yin J., Mori Y., et al. Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 21 (2002) 475-478
29. Helm J., Enkemann S.A., Coppola D., Barthel J.S., Kelley S.T., and Yeatman T.J. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res 11 (2005) 2478-2485
30. Watson D.I., Wijnhoven B.P., Michael M.Z., Mayne G.C., and Hussey D.J. Hp24 microRNA expression profiles in Barrett's oesophagus. ANZ J Surg 77 Suppl 1 (2007) A45
31. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
32. Cameron A.J. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus 15 (2002) 106-108
33. Wang S., Zhan M., Yin J., Abraham J.M., Mori Y., Sato F., et al. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 25 (2006) 3346-3356
34. Ramaswamy S., Tamayo P., Rifkin R., Mukherjee S., Yeang C.H., Angelo M., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98 (2001) 15149-15154
35. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102 (2005) 19075-19080
36. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103 (2006) 2257-2261
37. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (2005) 6029-6033
38. Cheng A.M., Byrom M.W., Shelton J., and Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33 (2005) 1290-1297